Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002582 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | completed | Phase 3 | 6,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00002662 | Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer | completed | Phase 3 | — | Aventis PharmaceuticalsINDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00002696 | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | suspended | Phase 3 | — | Grupo Oncologico Cooperativo del SurOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00005590 | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 3 | — | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00032136 | Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer | completed | Phase 3 | 4,400 | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00072020 | Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer | unknown | Phase 3 | — | University of SheffieldOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00559858 | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer | unknown | Phase 3 | 270 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00963209 | Tamoxifen Citrate in Patients With Breast Cancer | unknown | Phase 3 | 140 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01031030 | Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) | unknown | Phase 3 | 800 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00281697 | A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) | completed | Phase 3 | 684 | Genentech, Inc.INDUSTRY | 0 | Jul 26, 2013 | clinicaltrials |
| NCT00054587 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | completed | Phase 3 | 3,010 | UNICANCEROTHER | 1 | Jul 19, 2013 | clinicaltrials |
| NCT00311636 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | completed | Phase 3 | 280 | Gruppo Italiano Mammella (GIM)OTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00103233 | Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer | completed | Phase 3 | — | SWOG Cancer Research NetworkNETWORK | 0 | Jun 24, 2013 | clinicaltrials |
| NCT00711529 | Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes. | completed | Phase 3 | 27 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00002967 | Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer | completed | Phase 3 | — | NSABP Foundation IncNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00055679 | Combination Chemotherapy in Treating Women With Stage I Breast Cancer | completed | Phase 3 | 1,512 | UNICANCEROTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00671918 | Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma | completed | Phase 3 | 186 | Navidea BiopharmaceuticalsINDUSTRY | 2 | Jun 17, 2013 | clinicaltrials |
| NCT01106040 | Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes | completed | Phase 3 | 163 | Navidea BiopharmaceuticalsINDUSTRY | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00003440 | Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic | completed | Phase 3 | 580 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00047099 | Combination Chemotherapy in Treating Women With Breast Cancer | completed | Phase 3 | 446 | Ludwig-Maximilians - University of MunichOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00869674 | GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study | terminated | Phase 3 | 540 | Johnson & Johnson Medical, ChinaINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT01200212 | A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer(TABEA) | terminated | Phase 3 | 432 | GBG Forschungs GmbHOTHER | 1 | May 22, 2013 | clinicaltrials |
| NCT00005079 | Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01433562 | Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients | completed | Phase 2 / Phase 3 | 40 | Dexa Medica GroupINDUSTRY | 1 | May 13, 2013 | clinicaltrials |
| NCT00083304 | Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer(ENRICH) | completed | Phase 3 | 368 | Spectrum Pharmaceuticals, IncINDUSTRY | 15 | May 10, 2013 | clinicaltrials |
| NCT00847444 | Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention(SUCCESS-C) | unknown | Phase 3 | 3,547 | Philip HeppOTHER | 1 | Apr 19, 2013 | clinicaltrials |
| NCT00002528 | Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer(10-93) | completed | Phase 3 | 473 | ETOP IBCSG Partners FoundationNETWORK | 9 | Apr 4, 2013 | clinicaltrials |
| NCT00002529 | Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer(12-93) | completed | Phase 3 | 452 | ETOP IBCSG Partners FoundationNETWORK | 7 | Apr 4, 2013 | clinicaltrials |
| NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer(15-95) | completed | Phase 3 | 344 | ETOP IBCSG Partners FoundationNETWORK | 2 | Apr 4, 2013 | clinicaltrials |
| NCT00003638 | Vaccine Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 3 | 950 | Oncothyreon Canada Inc.INDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01134523 | Regimens Comparison for Breast Cancers of Positive Lymph Nodes | unknown | Phase 3 | 1,000 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT00122356 | Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment(BATMAN) | completed | Phase 3 | 303 | Barwon HealthOTHER_GOV | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00326820 | Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer | unknown | Phase 3 | 1,404 | Wales Cancer Trials UnitOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT01803139 | Long Term Results of the Canadian Breast IMRT Study(IMRT-FU) | unknown | Phase 3 | 358 | Sunnybrook Health Sciences CentreOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00440622 | Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients | terminated | Phase 3 | 90 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00008203 | Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer | completed | Phase 3 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00291759 | ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation. | completed | Phase 3 | 3,858 | AstraZenecaINDUSTRY | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00002772 | S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | terminated | Phase 3 | 602 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005983 | S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer | terminated | Phase 3 | 98 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00016406 | S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer | completed | Phase 3 | 399 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00929591 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | completed | Phase 3 | 1,558 | SWOG Cancer Research NetworkNETWORK | 0 | Jan 24, 2013 | clinicaltrials |
| NCT00016276 | Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | terminated | Phase 3 | 396 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01611051 | A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy | completed | Phase 3 | 330 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00262899 | Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions | completed | Phase 3 | 331 | Georgetown UniversityOTHER | 1 | Jan 7, 2013 | clinicaltrials |
| NCT01752686 | A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer | unknown | Phase 3 | 587 | Severance HospitalOTHER | 0 | Dec 25, 2012 | clinicaltrials |
| NCT00089479 | A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer | completed | Phase 3 | 2,611 | Hoffmann-La RocheINDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00230711 | Physical Activity Promotion in Cancer Follow-Up Care | completed | Phase 3 | 300 | The Miriam HospitalOTHER | 1 | Nov 30, 2012 | clinicaltrials |
| NCT00324714 | Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS | withdrawn | Phase 3 | 0 | ETOP IBCSG Partners FoundationNETWORK | 1 | Nov 29, 2012 | clinicaltrials |
| NCT00002920 | S9630, Medroxyprogesterone in Treating Women With Breast Cancer | completed | Phase 3 | 313 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 31, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Aug 2, 2013source: clinicaltrials